Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium infusion for conversion of atrial fibrillation/atrial flutter
2011-005525-48Phase 4Completed
- Sponsor
- Diakonhjemmet Sykehus
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of potassium chloride in Atrial fibrillation (AFib) and atrial flutter (AFL), sponsored by Diakonhjemmet Sykehus. Primary endpoint: Time to conversion of atrial fibrillation to sinus rhythm. Started May 2012; status: completed.
02
Drugs
potassium chloride
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on 2011-005525-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005525-48.